Concurrent injection of cold antibody allows PET imaging of orthotopic pancreatic tumor with "Cu -labeled anti -PD-L1

被引：0
|
作者：
Wen, Xiaoxia [3 ]
Zhao, Jun [3 ]
Wen, Xiaofei [1 ]
Shi, Sixiang [3 ]
Li, Tingting [2 ]
Li, Chun [3 ]
机构：
[1] Harbin Med Univ, Hosp 4, Harbin, Heilongjiang, Peoples R China
[2] Univ Elect Sci & Technol China, Chengdu, Sichuan, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
607
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models
    Bansal, Aditya
    Lavoie, Roxane R.
    Lucien, Fabrice
    Kethamreddy, Manasa
    Wootla, Bharath
    Dong, Haidong
    Park, Sean S.
    Pandey, Mukesh K.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [12] Immuno PET imaging of PD-L1 expression in syngeneic and human xenograft tumor mouse models using a site-specific 89Zr labeled PD-L1 antibody
    Christensen, Camilla
    Kristensen, Lotte K.
    Toftevall, Hanna
    Nordgren, Maria
    Agnew, Brian J.
    Nielsen, Carsten H.
    Kjaer, Andreas
    CANCER RESEARCH, 2018, 78 (13)
  • [13] PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
    Lv, Gaochao
    Sun, Xiaorong
    Qiu, Ling
    Sun, Yan
    Li, Ke
    Liu, Qingzhu
    Zhao, Qi
    Qin, Songbing
    Lin, Jianguo
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 117 - 122
  • [14] Immuno-PET imaging of 89Zr labeled anti-PD-L1domain antibody
    Li, Dan
    Cheng, Siyuan
    Zhu, Xiao-Hua
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [15] Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody
    Li, Dan
    Cheng, Siyuan
    Zou, Sijuan
    Zhu, Dongling
    Zhu, Tinghui
    Wang, Pilin
    Zhu, Xiaohua
    MOLECULAR PHARMACEUTICS, 2018, 15 (04) : 1674 - 1681
  • [16] PET imaging of radiation-induced PD-L1 upregulation in the tumor microenvironment using a Zr-89 labeled PD-L1 monoclonal Ab in a mouse model
    Kikuchi, Masahiro
    Srivastava, Raghvendra
    Sun, Lingyi
    Zeng, Dexing
    Diaz-Perez, Julio
    Anderson, Carolyn
    Ferris, Robert
    Edwards, W. Barry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [17] Concurrent Injection of Unlabeled Antibodies Allows Positron Emission Tomography Imaging of Programmed Cell Death Ligand 1 Expression in an Orthotopic Pancreatic Tumor Model
    Zhao, Jun
    Wen, Xiaoxia
    Li, Tingting
    Shi, Sixiang
    Xiong, Chiyi
    Wang, Yaoqi Alan
    Li, Chun
    ACS OMEGA, 2020, 5 (15): : 8474 - 8482
  • [18] Dose-dependent targeting of 89Zr-labeled atezolizumab (anti-PD-L1 antibody) to PD-L1 expressing tumor xenografts
    Longtine, Mark
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [19] HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC
    Funaishi, Kunihiko
    Yamaguchi, Kakuhiro
    Tanahashi, Hiroki
    Kurose, Koji
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Iwamoto, Hiroshi
    Hamada, Hironobu
    Oga, Toru
    Oka, Mikio
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [20] 68Ga-labeled non-blocking nanobody for targeting PET imaging of tumor PD-L1 expression
    Lv, Gaochao
    Qiu, Ling
    Li, Ke
    Liu, Qingzhu
    Lin, Jianguo
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S466 - S466
12345